EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NSUN2-mediated m5C modification of HBV RNA positively regulates HBV replication

Jiangpeng Feng, Tianmo Xu, Miao He, Jiali Li, Peipei Yao, Chengbao Ma, Shimin Yang, Zaichao Xu, Kun Yan, Xianying Chen, Hongyun Wang, Jiejie Liu und 5 weitere

PLOS Pathogens · 04.12.2023 · 19 (12) · e1011808

DOI: 10.1371/journal.ppat.1011808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 04.12.2023. Verfasst von Jiangpeng Feng und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Virology, RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University…. Hauptthemen laut MEDLINE: Hepatitis B virus, Hepatitis B, Chronic. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic hepatitis B virus (HBV) infection is a major cause of liver cirrhosis and liver cancer, despite strong prevention and treatment efforts. The study of the epigenetic modification of HBV has become a research hotspot, including the N 6-methyladenosine (m 6 A) modification of HBV RNA, which plays complex roles in the HBV life cycle. In addition to m 6 A modification, 5-methylcytosine (m 5 C) is another major modification of eukaryotic mRNA. In this study, we explored the roles of m 5 C methyltransferase and demethyltransferase in the HBV life cycle. The results showed that m 5 C methyltransferase NSUN2 deficiency could negatively regulate the expression of HBV while m 5 C demethyltransferase TET2 deficiency positively regulates the expression of HBV. Subsequently, we combined both in vitro bisulfite sequencing and high-throughput bisulfite sequencing methods to determine the distribution and stoichiometry of m 5 C modification in HBV RNA. Two sites: C2017 and C131 with the highest-ranking methylation rates were identified, and mutations at these two sites could lead to the decreased expression and replication of HBV, while the mutation of the “fake” m 5 C site had no effect. Mechanistically, NSUN2-mediated m 5 C modification promotes the stability of HBV RNA. In addition, compared with wild-type HepG2-NTCP cells and primary human hepatocytes, the replication level of HBV after NSUN2 knockdown decreased, and the ability of the mutant virus to infect and replicate in wild-type HepG2-NTCP cells and PHHs was substantially impaired. Similar results were found in the experiments using C57BL/6JGpt- Nsun2 +/- mice. Interestingly, we also found that HBV expression and core protein promoted the endogenous expression of NSUN2, which implied a positive feedback loop. In summary, our study provides an accurate and high-resolution m 5 C profile of HBV RNA and reveals that NSUN2-mediated m 5 C modification of HBV RNA positively regulates HBV replication by maintaining RNA stability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusHepatitis B, ChronicAnimalsHumansMiceMethyltransferasesMice, Inbred C57BLRNASulfites

Substanzen

MethyltransferasesRNAhydrogen sulfiteSulfitesNSUN2 protein, humanMisu protein, mouse

Autor:innen und Institutionen

  • State Key Laboratory of Virology, RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
  • Animal Bio-safety Level III Laboratory/Institute for Vaccine Research, Wuhan University School of Medicine, Wuhan, China.
  • School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • Wuhan University Taikang Medical School (School of Basic Medical Sciences), Wuhan, China.
  • School of Basic Medical Sciences, Fudan University, Shanghai, China.

ORCID-Profile: Yu Chen

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Feng, J., Xu, T., He, M., Li, J., Yao, P., Ma, C., Yang, S., Xu, Z., Yan, K., Chen, X., Wang, H., Liu, J., Zeng, C., Xia, Y., Yan, H., Zhou, L., & Chen, Y. (2023). NSUN2-mediated m5C modification of HBV RNA positively regulates HBV replication. PLOS Pathogens, 19(12), e1011808. https://doi.org/10.1371/journal.ppat.1011808

Vancouver

Feng J, Xu T, He M, Li J, Yao P, Ma C, et al. NSUN2-mediated m5C modification of HBV RNA positively regulates HBV replication. PLOS Pathogens. 2023;19(12):e1011808. doi:10.1371/journal.ppat.1011808

BibTeX
@article{Feng2023,
  author = {Feng, Jiangpeng and Xu, Tianmo and He, Miao and Li, Jiali and Yao, Peipei and Ma, Chengbao and Yang, Shimin and Xu, Zaichao and Yan, Kun and Chen, Xianying and Wang, Hongyun and Liu, Jiejie and Zeng, Cong and Xia, Yuchen and Yan, Huan and Zhou, Li and Chen, Yu},
  title = {NSUN2-mediated m5C modification of HBV RNA positively regulates HBV replication},
  journal = {PLOS Pathogens},
  year = {2023},
  volume = {19},
  number = {12},
  pages = {e1011808},
  doi = {10.1371/journal.ppat.1011808}
}
Kostenlos starten →